Biotechnology Analysis & Statistics in the United States, April 2011 (p20)

Talk to Amrita

+1 718 303 2019

Search inside this page

All regions

You might be interested in: biotech, biomedical, protein, more »

571-600 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, Q2 2011

Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Biological Therapy
  • Countries : United States
Legal Services Industry: ZymoGenetics, Inc. - Strategy and SWOT Report

Legal Services Industry: ZymoGenetics, Inc. - Strategy and SWOT Report

  • $ 175
  • Company report
  • April 2011
  • by MarketLine

Datamonitors' ZymoGenetics, Inc.?s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive industry player data and information. The market research report covers the firm ?s structure, ...

  • Industries : Biopharmaceutical
  • Countries : United States
US Stem Cell Market Analysis

US Stem Cell Market Analysis

  • $ 800
  • Industry report
  • April 2011
  • by RNCOS

The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in this industry. Using stem ...

  • Industries : Biological Therapy
  • Countries : United States
ZymoGenetics, Inc. SWOT

ZymoGenetics, Inc. SWOT

  • $ 175
  • Company report
  • April 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ZymoGenetics, a wholly-owned subsidiary of Bristol-Myers ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biomaterials that Deliver Antimicrobials: An Overview

Biomaterials that Deliver Antimicrobials: An Overview

  • $ 500
  • Industry report
  • March 2011
  • by Global Data

The report provides key industry ed products, key players and industry dynamics. The report provides comprehensive data on the industry drivers and restraints affecting the industry growth. Scope of the ...

  • Industries : Biomaterial
  • Countries : United States
Biopharmaceutical Industry: Keryx Biopharmaceuticals, Inc. ? Product Pipeline Review - Q1 2011

Biopharmaceutical Industry: Keryx Biopharmaceuticals, Inc. ? Product Pipeline Review - Q1 2011

  • $ 500
  • Company report
  • March 2011
  • by Global Markets Direct

- Product Pipeline Review - Q1 2011? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q1 2011

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q1 2011

  • $ 500
  • Company report
  • March 2011
  • by Global Markets Direct

- Product Pipeline Review - Q1 2011? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

  • $ 3 500
  • Industry report
  • March 2011
  • by GBI Research

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market Summary GBI Research's report, ?Upstream Processing in Biopharmaceuticals ...

  • Industries : Biopharmaceutical
  • Countries : United States, Japan, India
Millipore Corporation (MIL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Millipore Corporation (MIL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2011
  • by Global Data

Millipore Corporation (MIL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Millipore Corporation (Millipore) is a life sciences company. The company provides innovative products, ...

  • Industries : Biopharmaceutical
  • Countries : United States
RegeneRx Biopharmaceuticals, Inc. (RGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RegeneRx Biopharmaceuticals, Inc. (RGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2011
  • by Global Data

RegeneRx Biopharmaceuticals, Inc. (RGN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is publicly held US based ...

  • Industries : Biopharmaceutical
  • Countries : Australia, United States
Embryome Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Embryome Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2011
  • by Global Data

Embryome Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Embryome Sciences, Inc. (Embryome Sciences) focuses on products for the differentiation and expansion of human ...

  • Industries : Biological Therapy
  • Countries : United States
ARIUS Research Inc. (ARI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ARIUS Research Inc. (ARI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2011
  • by Global Data

ARIUS Research Inc. (ARI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary ARIUS Research Inc. is a biotechnology company that is engaged in the discovery and development of antibody ...

  • Industries : Biological Therapy
  • Countries : United States
Bioinformatics - A Global Market Overview

Bioinformatics - A Global Market Overview

  • $ 4 320
  • Industry report
  • March 2011
  • by Industry Experts

At the beginning of the ?genomic revolution?, Bioinformatics was applied in creating and maintaining a database that stored biological information, such as nucleotide and amino acid sequences. Development ...

  • Industries : Genomics, Biotechnology
  • Countries : World, Europe, United Kingdom, India, United States, Germany, France, Japan
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Raven biotechnologies, Inc.

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Raven biotechnologies, Inc.

  • $ 250
  • Company report
  • March 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
Strategic Analysis of the U.S. Next Generation Sequencing Markets

Strategic Analysis of the U.S. Next Generation Sequencing Markets

  • $ 6 000
  • Industry report
  • March 2011
  • by Frost & Sullivan

This research service provides a strategic analysis of the next generation sequencing market. This study provides a detailed overview of the next generation sequencing instruments on the market, an analysis ...

  • Industries : Genomics
  • Countries : United States
Monoclonal Antibodies: A Segment of Major Growth

Monoclonal Antibodies: A Segment of Major Growth

  • $ 3 195
  • Industry report
  • March 2011
  • by CHI Insight Pharma Reports

Monoclonal antibodies are highly valuable therapeutic agents and were among the best-selling drugs in the world in 2010. Global revenues from monoclonal antibody products will have moved significantly ...

  • Industries : Biopharmaceutical
  • Countries : United States
What's For Dinner 2011: Trends in Center of Plate Proteins

What's For Dinner 2011: Trends in Center of Plate Proteins

  • $ 3 995
  • Industry report
  • March 2011
  • by Packaged Facts

Continuing behaviors adopted during the recession, American consumers are eating in more, which is beneficial to the fresh protein businesses of meat, poultry and seafood alike. However, consumers are ...

  • Industries : Sport Nutritional, Biotechnology
  • Countries : United States
Targeted Genetics Corporation (Symbol:TGEN) SWOT Analysis, Strategy, Revenues and Profits

Targeted Genetics Corporation (Symbol:TGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • February 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
Competitor Analysis Cancer Antibodies in Early Clinical Develoment

Competitor Analysis Cancer Antibodies in Early Clinical Develoment

  • $ 1 188
  • Industry report
  • February 2011
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about Cancer Antibodies in Early Clinical Development provides a competitor evaluation in the field of antibody therapeutics being developed ...

  • Industries : Biopharmaceutical
  • Countries : United States
US Stem Cells Research Industry

US Stem Cells Research Industry

  • $ 4 500
  • Industry report
  • February 2011
  • by Global Industry Analysts

This report analyzes the US Market for Stem Cells Research in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 92 companies including many key and niche ...

  • Industries : Biological Therapy
  • Countries : United States
Biomarkers in Parkinson`s Disease, 2011

Biomarkers in Parkinson`s Disease, 2011

  • $ 2 324
  • Industry report
  • January 2011
  • by BioPharm Reports

This report presents a comprehensive update on PD biomarker developments up to 2010. It covers the major classes of emerging and new markers relating to PD (blood, CSF, metabolomic, image-based, genetic ...

  • Industries : Genomics
  • Countries : United States
U.S. Preimplantation Genetic Diagnosis Market

U.S. Preimplantation Genetic Diagnosis Market

  • $ 6 000
  • Industry report
  • December 2010
  • by Frost & Sullivan

This research service analyzes the market for the preimplantation genetic diagnosis (PGD) market. Key market drivers and restraints are ranked and discussed. PGD revenue forecasts are modeled largely on ...

  • Industries : Genomics
  • Countries : United States
Biopharmaceutical Industry: Growth Hormone Deficiency - Pipeline Review, Q4 2010

Biopharmaceutical Industry: Growth Hormone Deficiency - Pipeline Review, Q4 2010

  • $ 500
  • Company report
  • December 2010
  • by Global Markets Direct

This report provides data on the therapeutic development for Growth Hormone Deficiency   , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions

  • $ 3 500
  • Industry report
  • December 2010
  • by GBI Research

Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions Summary GBI Research, the leading business intelligence provider, has released its latest ...

  • Industries : Biopharmaceutical
  • Countries : World, United States, Japan, Europe
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q4 2010

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q4 2010

  • $ 500
  • Company report
  • December 2010
  • by Global Markets Direct

- Product Pipeline Review - Q4 2010? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Genetic Technologies Limited SWOT Analysis, Strategy, Revenues and Profits

Genetic Technologies Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2010
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
InNexus Biotechnology Inc. SWOT Analysis, Strategy, Revenues and Profits

InNexus Biotechnology Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2010
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada, United States, United Kingdom
Biological Therapy: Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients

Biological Therapy: Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients

  • $ 500
  • Company report
  • November 2010
  • by Global Data

What's inside this report? Industry expert's report, ?? provides key data, data on the scope of Stem Cell Therapy in cardiovascular disease. Research Scope - Data and data on the most commonly reprocessed ...

  • Industries : Biological Therapy
  • Countries : United States
Amgen: Pipeline - Products ? Performance - Potential

Amgen: Pipeline - Products ? Performance - Potential

  • $ 1 041
  • Company report
  • November 2010
  • by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

  • Industries : Biological Therapy
  • Countries : United States, Europe, Australia
ImmunoGen, Inc.: SWOT Analysis & Company Profile

ImmunoGen, Inc.: SWOT Analysis & Company Profile

  • $ 99
  • Company report
  • November 2010
  • by Business Review

Synopsis Business Review's ImmunoGen, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis company ...

  • Industries : Biopharmaceutical
  • Countries : United States
About 2 700 reports

Download Unlimited Documents from Trusted Public Sources

Global Vaccine Industry

  • Vaccines and Global Health: the Week in Review
  • July 2014
    38 pages
  • Vaccine  

  • United States  

    Pakistan  

    World  

View report >

17 Companies

Read our Company Profiles

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

Biogen Idec

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.